Vaccinex, Inc. Repayments of Long-Term Debt
Vaccinex, Inc. (VCNX) reported Repayments of Long-Term Debt of $76.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2025-04-15
- Vaccinex, Inc. repayments of long-term debt for the quarter ending 2024-12-31 was $18.00K, a 5.88% increase year-over-year.
- Vaccinex, Inc. repayments of long-term debt for the quarter ending 2024-09-30 was $32.00K, a 68.42% increase year-over-year.
- Vaccinex, Inc. repayments of long-term debt for the quarter ending 2024-06-30 was $7.00K, a 63.16% decline year-over-year.
- Vaccinex, Inc. repayments of long-term debt for the quarter ending 2024-03-31 was $19.00K, a 0.00% change year-over-year.
- Vaccinex, Inc. repayments of long-term debt for fiscal 2024 was $76.00K, a 2.70% increase from fiscal 2023.
- Vaccinex, Inc. repayments of long-term debt for fiscal 2023 was $74.00K, a 1.33% decline from fiscal 2022.
- Vaccinex, Inc. repayments of long-term debt for fiscal 2022 was $75.00K, a 733.33% increase from fiscal 2021.
- Vaccinex, Inc. repayments of long-term debt for fiscal 2021 was $9.00K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $50.00K derived: sum of 2 quarters · filed 2025-04-15 | $57.00K derived: sum of 3 quarters · filed 2025-04-15 | $76.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $39.00K derived: sum of 2 quarters · filed 2024-11-14 | $58.00K 10-Q · filed 2024-11-14 | $75.00K derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $26.00K 10-Q · filed 2024-08-14 | $43.00K derived: sum of 3 quarters · filed 2025-04-15 | $62.00K derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-03-31 | $19.00K 10-Q · filed 2024-05-15 | $36.00K derived: sum of 2 quarters · filed 2025-04-15 | $55.00K derived: sum of 3 quarters · filed 2025-04-15 | $74.00K derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $36.00K derived: sum of 2 quarters · filed 2025-04-15 | $55.00K derived: sum of 3 quarters · filed 2025-04-15 | $74.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $38.00K derived: sum of 2 quarters · filed 2024-11-14 | $57.00K 10-Q · filed 2024-11-14 | $76.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $38.00K 10-Q · filed 2024-08-14 | $57.00K derived: sum of 3 quarters · filed 2024-08-14 | $76.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $19.00K 10-Q · filed 2024-05-15 | $38.00K derived: sum of 2 quarters · filed 2024-05-15 | $57.00K derived: sum of 3 quarters · filed 2024-05-15 | $75.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $19.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-25 | $38.00K derived: sum of 2 quarters · filed 2024-04-25 | $56.00K derived: sum of 3 quarters · filed 2024-04-25 | $75.00K 10-K/A · filed 2024-04-25 |
| 2022-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $37.00K derived: sum of 2 quarters · filed 2023-11-13 | $56.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $37.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $19.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $9.00K 10-K · filed 2023-03-31 |